US › Healthcare

Cibus Global LLC (CBUS)

US · Healthcare · Biotechnology

$1.92+1.59%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.7M
Revenue YoY
+62.6%
Net profit
$-21.2M
Profit YoY
+54.7%
EPS
$-0.33
EPS estimate
$-0.12
Net margin
-1,262.5%

EPS came in at -0.33 against a street estimate of -0.12 — a miss of 175.0%.

Key statistics

Market cap
$156.3M
Forward P/E
0.0
P/B
4.15
Book value
$0.47
EPS (TTM)
$-1.77
52-week high
$4.19
52-week low
$1.09
50-day MA
$1.56
200-day MA
$1.84
Beta
1.65

Analyst view

Analysts rate Cibus Global LLC a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $14.67.

Shareholding

Insiders
26.13%
Institutions
33.60%

Largest institutional holders

FundStake
FMR Inc14.98%
Vanguard Capital Management, LLC2.78%
Davidson Kempner Capital Management LP2.00%
Weiss Asset Management LP1.16%
United Capital Financial Advisers Inc0.76%
Geode Capital Management, LLC0.63%
Millennium Management LLC0.56%
BlackRock Inc0.54%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cibus Global LLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.